πŸ›οΈ Verified NIH Record β€’ Updated 2026-05-27

Communication Bridge 3 Study (NCT06191198)

Communication Bridge: Optimizing an Evidence-based Intervention for Individuals With Primary Progressive Aphasia

🟒 Recruiting Phase2 🧠 Behavioral & Psychological Program Sponsor: University of Chicago

🩺 Plain-English Summary (8th-Grade Level)

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

Who can join: Review the eligibility criteria below.

Location: University of Chicago - American School Building β€” Chicago, Illinois

Age range: 18 Years to 100 Years

πŸ§ͺ Interventions in This Study

  • Communication Bridgeβ„’ (BEHAVIORAL)
  • Evidence-Based Impairment Focused (BEHAVIORAL)

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (1 Sites)

  • University of Chicago - American School Building β€” Chicago, Illinois

πŸ“ž Contact the Study Coordinator

Phone: (773) 702-1220

Email: cbtrial@uchicago.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—